The vaccine was registered on 11 August 2020 by the Ministry of Health of the Russian Federation.[1][2] As of 8 August 2020 the scientific report on the Gam-COVID-Vac clinical trials has not yet been published.[3] The German newspaper Der Tagesspiegel, with reference to Russian officials, claimed that more than 20 countries including India, Brazil and Saudi Arabia, have shown interest in the Russian vaccine.[4]